Skip to content

CORIX BIOSCIENCE, INC.: 10-Q/A filed 2012-09-14

What CORIX BIOSCIENCE, INC. reported in its quarterly report amendment filed 2012-09-14 (fiscal Q2 2012): 20 published measures, 61 facts as tagged in accession 0001178924-12-000143.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-Q/A (quarterly report amendment)
Filed
2012-09-14
Fiscal period
fiscal Q2 2012
Accession
0001178924-12-000143 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All CORIX BIOSCIENCE, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-07-316USD
At 2012-01-316USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-07-313,833USD
At 2012-01-3113,039USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-07-316USD
At 2012-01-316USD
At 2012-01-306USD
At 2011-07-319USD
At 2011-01-309USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-05-01 to 2012-07-31-1,679,453USD92
2012-01-31 to 2012-07-31-1,680,953USD183
2007-12-17 to 2012-07-31-2,662,128USD1689
2011-05-01 to 2011-07-31-32,706USD92
2011-01-31 to 2011-07-31-64,206USD182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-31 to 2012-07-31-1,050USD183
2007-12-17 to 2012-07-31-60,224USD1689
2011-01-31 to 2011-07-310USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-31 to 2012-07-311,050USD183
2007-12-17 to 2012-07-3160,230USD1689
2011-01-31 to 2011-07-310USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-07-31-2,662,128USD
At 2012-01-31-981,175USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-05-01 to 2012-07-31-4,332USD92
2012-01-31 to 2012-07-31-5,832USD183
2007-12-17 to 2012-07-31-986,463USD1689
2011-05-01 to 2011-07-31-32,706USD92
2011-01-31 to 2011-07-31-64,206USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-07-316USD
At 2012-01-316USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-05-01 to 2012-07-31-3USD92
2012-01-31 to 2012-07-31-3USD183
2007-12-17 to 2012-07-31-547USD1689

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-07-313,833USD
At 2012-01-3113,039USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-07-312,280USD
At 2012-01-3113,039USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-05-01 to 2012-07-314,332USD92
2012-01-31 to 2012-07-315,832USD183
2007-12-17 to 2012-07-31986,463USD1689
2011-05-01 to 2011-07-3132,706USD92
2011-01-31 to 2011-07-3164,206USD182

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2012-07-31-3,827USD
At 2012-01-31-13,033USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2012-05-01 to 2012-07-31-1,679,453USD92
2012-01-31 to 2012-07-31-1,680,953USD183
2007-12-17 to 2012-07-31-2,662,128USD1689
2011-05-01 to 2011-07-31-32,706USD92
2011-01-31 to 2011-07-31-64,206USD182

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2012-01-31 to 2012-07-31-1,680,953USD183
2007-12-17 to 2012-07-31-2,662,128USD1689
2011-01-31 to 2011-07-31-64,206USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-05-01 to 2012-07-311,482USD92
2012-01-31 to 2012-07-311,482USD183
2007-12-17 to 2012-07-3114,638USD1689

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2012-05-01 to 2012-07-31-1,680,000USD92
2012-01-31 to 2012-07-31-1,680,000USD183
2007-12-17 to 2012-07-31-1,680,000USD1689

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2007-12-17 to 2012-07-3150,830USD1689

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-01-31 to 2012-07-311,282USD183
2007-12-17 to 2012-07-31258,592USD1689
2011-01-31 to 2011-07-3161,206USD182

Inspect the source

Entity
CORIX BIOSCIENCE, INC. / CIK 0001433821
Captured
SEC response SHA-256
83bf56b0a57d4bb31413a41a5bf482e2202ff4890c0e95b25620534c9d887dab

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001433821.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))